Literature DB >> 16230448

Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance.

T A M Kaandorp, H J Lamb, J J Bax, E Boersma, E P Viergever, E E van der Wall, A de Roos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16230448      PMCID： PMC1769186          DOI： 10.1136/hrt.2004.051425

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms.

Authors:  J J Bax; F C Visser; D Poldermans; A Elhendy; J H Cornel; E Boersma; R Valkema; A Van Lingen; P M Fioretti; C A Visser
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

2.  Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance.

Authors:  N G Bellenger; L C Davies; J M Francis; A J Coats; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2000       Impact factor: 5.364

3.  Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).

Authors:  P Lechat; S Escolano; J L Golmard; H Lardoux; S Witchitz; J A Henneman; B Maisch; M Hetzel; P Jaillon; J P Boissel; A Mallet
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

4.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

5.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245
  5 in total
  6 in total

1.  Pharmacological stress: a useful exercise?

Authors:  E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2009-01-15       Impact factor: 2.357

Review 2.  Cardiac stress MR imaging with dobutamine.

Authors:  K Strach; C Meyer; H Schild; T Sommer
Journal:  Eur Radiol       Date:  2006-05-20       Impact factor: 5.315

3.  Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging.

Authors:  Frederic Mouquet; Christophe Lions; Pascal de Groote; Nadia Bouabdallaoui; Serge Willoteaux; Joel Dagorn; Philippe Deruelle; Nicolas Lamblin; Christophe Bauters; Jean Paul Beregi
Journal:  Eur Radiol       Date:  2008-07-19       Impact factor: 5.315

Review 4.  The 20 year evolution of dobutamine stress cardiovascular magnetic resonance.

Authors:  Charaslak Charoenpanichkit; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2010-10-26       Impact factor: 5.364

5.  Relation between regional and global systolic function in patients with ischemic cardiomyopathy after beta-blocker therapy or revascularization.

Authors:  T A M Kaandorp; J J Bax; S E Bleeker; J Doornbos; E P Viergever; D Poldermans; E E van der Wall; A de Roos; H J Lamb
Journal:  J Cardiovasc Magn Reson       Date:  2010-01-27       Impact factor: 5.364

6.  Effect of race on left ventricular ejection fraction decline after initial improvement with beta blockers in patients with non-ischemic cardiomyopathy: a retrospective analysis.

Authors:  Iosif Kelesidis; Patrick Hourani; Christopher Varughese; Ronald Zolty
Journal:  Drugs R D       Date:  2013-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.